 |
ALX Oncology
Last updated: April 19, 2024
Founder Jaume Pons
Country: USA | Funding: $329.2M (+)
Website: http://alxoncology.com/
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Website: http://alxoncology.com/
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.